microdose glp 1 side effects nausea at night GLP-1 Effects: A Complete Guide to What You Can Expect People Are Microdosing Weight-Loss Drugs

While not a direct predictor of semaglutide itching, variants in genes affecting inflammation (like those controlling cytokine release) can flag higher risk, helping your PlexusDx provider personalize your compound and dosing strategy to minimize dermatological side effects

reported only minor cardiovascular effects despite increased insulin levels and reduced plasma glucose concentration, in patients without diabetes but with compensated heart failure [80]

doi: 10.1002/ptr.7996

GIP Glucose-Dependent Insulinotropic Polypeptide Incretin K (K-cell) (Duodenum) GLP-1 GLP-1 receptor GIP receptor 2 GLP-1 2 GLP-1 (Glucagon-like Peptide-1) GIP (Glucose-dependent Insulinotropic Polypeptide) Mounjaro (Tirzepatide) GLP-1 GIP Mounjaro (Tirzepatide) GLP-1 GIP Dual GIP/GLP-1 Receptor Agonist : : SURMOUNT-1 tirzepatide semaglutide SURMOUNT-5 tirzepatide semaglutide 47% (Rubino et al., 2026, NEJM) : 3 (Triple agonist : GLP-1, GIP, Glucagon) Retatrutide 3 FAQ GLP-1 GIP GLP-1/GIP

How Semaglutide Works Beyond Weight Loss Semaglutide activates GLP-1 receptors throughout the body, triggering cascades that extend far beyond appetite suppression